nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR2—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00449	0.00449	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—BDNF—atopic dermatitis	0.00445	0.00445	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00443	0.00443	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00433	0.00433	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.00433	0.00433	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.00432	0.00432	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.0043	0.0043	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00427	0.00427	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00427	0.00427	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00419	0.00419	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00417	0.00417	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL27—atopic dermatitis	0.00415	0.00415	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL4—atopic dermatitis	0.00414	0.00414	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL11—atopic dermatitis	0.00413	0.00413	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00408	0.00408	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.00402	0.00402	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00401	0.00401	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00394	0.00394	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00394	0.00394	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00394	0.00394	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00393	0.00393	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00387	0.00387	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00387	0.00387	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00387	0.00387	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL11—atopic dermatitis	0.00381	0.00381	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL17—atopic dermatitis	0.00373	0.00373	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.0037	0.0037	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00364	0.00364	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00364	0.00364	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00363	0.00363	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00361	0.00361	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00357	0.00357	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.00356	0.00356	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.0034	0.0034	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00339	0.00339	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00338	0.00338	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR3—atopic dermatitis	0.00337	0.00337	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00334	0.00334	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL22—atopic dermatitis	0.00329	0.00329	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCL27—atopic dermatitis	0.00323	0.00323	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00322	0.00322	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.00316	0.00316	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00313	0.00313	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00312	0.00312	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR3—atopic dermatitis	0.00311	0.00311	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00305	0.00305	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL22—atopic dermatitis	0.00304	0.00304	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—NPS—atopic dermatitis	0.003	0.003	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—TAC1—atopic dermatitis	0.003	0.003	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL11—atopic dermatitis	0.003	0.003	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.00298	0.00298	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCR3—atopic dermatitis	0.00295	0.00295	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL27—atopic dermatitis	0.00293	0.00293	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00292	0.00292	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00289	0.00289	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00287	0.00287	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00287	0.00287	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00283	0.00283	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00281	0.00281	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00281	0.00281	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—TAC1—atopic dermatitis	0.00277	0.00277	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—NPS—atopic dermatitis	0.00277	0.00277	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00272	0.00272	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL27—atopic dermatitis	0.00271	0.00271	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00269	0.00269	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL17—atopic dermatitis	0.00263	0.00263	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00263	0.00263	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00261	0.00261	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IFNG—atopic dermatitis	0.0025	0.0025	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00248	0.00248	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR3—atopic dermatitis	0.00245	0.00245	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL17—atopic dermatitis	0.00243	0.00243	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00242	0.00242	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL22—atopic dermatitis	0.00239	0.00239	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL10—atopic dermatitis	0.00238	0.00238	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.00236	0.00236	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00235	0.00235	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CXCL8—atopic dermatitis	0.00232	0.00232	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00227	0.00227	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.00227	0.00227	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00224	0.00224	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1B—atopic dermatitis	0.00223	0.00223	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL2—atopic dermatitis	0.00222	0.00222	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.0022	0.0022	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00219	0.00219	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—NPS—atopic dermatitis	0.00218	0.00218	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—TAC1—atopic dermatitis	0.00218	0.00218	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00214	0.00214	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL27—atopic dermatitis	0.00213	0.00213	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL11—atopic dermatitis	0.00212	0.00212	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FCER2—atopic dermatitis	0.00209	0.00209	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL5—atopic dermatitis	0.00205	0.00205	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00202	0.00202	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL11—atopic dermatitis	0.00196	0.00196	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00196	0.00196	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL22—atopic dermatitis	0.00194	0.00194	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FCER2—atopic dermatitis	0.00193	0.00193	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL17—atopic dermatitis	0.00191	0.00191	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR3—atopic dermatitis	0.0019	0.0019	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL5—atopic dermatitis	0.00189	0.00189	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.00186	0.00186	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR5—atopic dermatitis	0.00185	0.00185	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00184	0.00184	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL22—atopic dermatitis	0.00179	0.00179	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.00178	0.00178	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00176	0.00176	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.00176	0.00176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL27—atopic dermatitis	0.00173	0.00173	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00173	0.00173	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR3—atopic dermatitis	0.00173	0.00173	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR5—atopic dermatitis	0.0017	0.0017	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.0017	0.0017	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—TAC1—atopic dermatitis	0.0017	0.0017	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—NPS—atopic dermatitis	0.0017	0.0017	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00166	0.00166	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.00164	0.00164	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—atopic dermatitis	0.00162	0.00162	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL27—atopic dermatitis	0.0016	0.0016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR3—atopic dermatitis	0.0016	0.0016	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00159	0.00159	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL5—atopic dermatitis	0.00158	0.00158	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.00157	0.00157	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—NPS—atopic dermatitis	0.00157	0.00157	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL17—atopic dermatitis	0.00155	0.00155	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TAC1—atopic dermatitis	0.00154	0.00154	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NPS—atopic dermatitis	0.00154	0.00154	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL11—atopic dermatitis	0.00154	0.00154	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00154	0.00154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FCER2—atopic dermatitis	0.00152	0.00152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCR3—atopic dermatitis	0.00151	0.00151	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL5—atopic dermatitis	0.00149	0.00149	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00147	0.00147	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL5—atopic dermatitis	0.00146	0.00146	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL17—atopic dermatitis	0.00143	0.00143	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL5—atopic dermatitis	0.00143	0.00143	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TAC1—atopic dermatitis	0.00142	0.00142	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NPS—atopic dermatitis	0.00142	0.00142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL22—atopic dermatitis	0.00141	0.00141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.00139	0.00139	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KIF3A—atopic dermatitis	0.00139	0.00139	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00138	0.00138	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00135	0.00135	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00135	0.00135	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR5—atopic dermatitis	0.00134	0.00134	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.00133	0.00133	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL5—atopic dermatitis	0.00132	0.00132	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—atopic dermatitis	0.00131	0.00131	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.00129	0.00129	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KIF3A—atopic dermatitis	0.00128	0.00128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL27—atopic dermatitis	0.00126	0.00126	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR3—atopic dermatitis	0.00126	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CMA1—atopic dermatitis	0.00125	0.00125	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL11—atopic dermatitis	0.00125	0.00125	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00124	0.00124	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—NPS—atopic dermatitis	0.00123	0.00123	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00123	0.00123	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL10—atopic dermatitis	0.00122	0.00122	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00121	0.00121	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT6—atopic dermatitis	0.00118	0.00118	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCL5—atopic dermatitis	0.00116	0.00116	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL11—atopic dermatitis	0.00116	0.00116	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CMA1—atopic dermatitis	0.00116	0.00116	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL5—atopic dermatitis	0.00115	0.00115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL17—atopic dermatitis	0.00113	0.00113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.00113	0.00113	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TAC1—atopic dermatitis	0.00112	0.00112	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NPS—atopic dermatitis	0.00112	0.00112	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL8—atopic dermatitis	0.00112	0.00112	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.0011	0.0011	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT6—atopic dermatitis	0.00109	0.00109	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.00107	0.00107	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00107	0.00107	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL5—atopic dermatitis	0.00105	0.00105	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.00104	0.00104	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR5—atopic dermatitis	0.00104	0.00104	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL5—atopic dermatitis	0.00104	0.00104	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.00103	0.00103	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR3—atopic dermatitis	0.00102	0.00102	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KIF3A—atopic dermatitis	0.00101	0.00101	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000978	0.000978	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000971	0.000971	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000963	0.000963	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR5—atopic dermatitis	0.000947	0.000947	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR3—atopic dermatitis	0.000943	0.000943	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TAC1—atopic dermatitis	0.00091	0.00091	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NPS—atopic dermatitis	0.00091	0.00091	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CMA1—atopic dermatitis	0.00091	0.00091	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL11—atopic dermatitis	0.00091	0.00091	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCR3—atopic dermatitis	0.000893	0.000893	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000888	0.000888	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000874	0.000874	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT6—atopic dermatitis	0.000856	0.000856	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL5—atopic dermatitis	0.000846	0.000846	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000841	0.000841	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NPS—atopic dermatitis	0.00084	0.00084	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TAC1—atopic dermatitis	0.00084	0.00084	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000824	0.000824	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000811	0.000811	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000808	0.000808	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL5—atopic dermatitis	0.000781	0.000781	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000764	0.000764	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000758	0.000758	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR3—atopic dermatitis	0.000742	0.000742	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL10—atopic dermatitis	0.000722	0.000722	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000688	0.000688	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000666	0.000666	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TAC1—atopic dermatitis	0.000662	0.000662	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPS—atopic dermatitis	0.000662	0.000662	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000649	0.000649	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000631	0.000631	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL5—atopic dermatitis	0.000621	0.000621	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL5—atopic dermatitis	0.000615	0.000615	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—atopic dermatitis	0.000603	0.000603	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000582	0.000582	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NGF—atopic dermatitis	0.000575	0.000575	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL5—atopic dermatitis	0.000573	0.000573	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—atopic dermatitis	0.000573	0.000573	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR5—atopic dermatitis	0.00056	0.00056	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—atopic dermatitis	0.000556	0.000556	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—atopic dermatitis	0.000547	0.000547	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NGF—atopic dermatitis	0.000531	0.000531	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000529	0.000529	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000524	0.000524	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR5—atopic dermatitis	0.000517	0.000517	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—atopic dermatitis	0.000505	0.000505	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKBIA—atopic dermatitis	0.000475	0.000475	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000458	0.000458	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL5—atopic dermatitis	0.000451	0.000451	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—atopic dermatitis	0.000438	0.000438	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000438	0.000438	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NGF—atopic dermatitis	0.000418	0.000418	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000416	0.000416	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR5—atopic dermatitis	0.000407	0.000407	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—atopic dermatitis	0.000398	0.000398	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000345	0.000345	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—atopic dermatitis	0.000338	0.000338	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—atopic dermatitis	0.000323	0.000323	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—atopic dermatitis	0.000322	0.000322	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—atopic dermatitis	0.000312	0.000312	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—atopic dermatitis	0.000298	0.000298	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK8—atopic dermatitis	0.000298	0.000298	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—atopic dermatitis	0.000297	0.000297	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK8—atopic dermatitis	0.000275	0.000275	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—atopic dermatitis	0.000246	0.000246	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—atopic dermatitis	0.000235	0.000235	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—atopic dermatitis	0.000234	0.000234	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK8—atopic dermatitis	0.000216	0.000216	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—atopic dermatitis	0.00019	0.00019	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—atopic dermatitis	0.000175	0.000175	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—atopic dermatitis	0.000138	0.000138	CbGpPWpGaD
